OakChart

Matinas Biopharma Holdings Inc

MTNBHealthcare·Biotechnology·USA·Nano·AMEX·Nov 11 • 3:59 PM ET

0.9300-0.3000 (-24.39%)
2026-11-11 22:35 CET
Market cap
1.20 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-7.31 USD m
Free cash flow, TTM
- USD m
EPS diluted, TTM
-18.01
P/E
-
Compare

Price

MTNB against its 20, 50 and 200-day averages
2050200
0.005.0010.0015.006.9M13.8MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MTNBclose 0.9320-day 1.5650-day 2.23200-day 6.640.93

95.2% under the 52-week high of 19.50 on 13 Nov 2025. 52-week low 0.81 on 11 Nov 2026. Last 15 sessions, 139.2% high to low

Volume 1.99× normal · the line is the 50-bar volume average

Profile

MTNB
52-week range, 0% of the way up
0.9719.50

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Employees4
IPOJul 21, 2014
Beta2.26
ATR, 14d0.26
Rel volume1.99
Short float4.62%
Insider own21.07%
Inst own1.83%

Snapshot

6 groups

Valuation

Index-
Market Cap0.91M
Enterprise Value0.11M
Income-7.31M
Sales0.00M
Book/sh4.21
Cash/sh0.83
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees4
IPOJul 21, 2014

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B0.22
P/C1.12
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio0.85
Current Ratio0.85
Debt/Eq0.01
LT Debt/Eq0.01
Option/ShortNo / Yes

Earnings

EPS (ttm)-18.01
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y25.49% 19.44%
Sales past 3/5Y- -
EPS Y/Y TTM68.91%
Sales Y/Y TTM-
EPS Q/Q79.92%
Sales Q/Q-
Earnings-
EPS/Sales Surpr.19.43% -

Ownership

Insider Own21.07%
Insider Trans0.00%
Inst Own1.83%
Inst Trans-1.08%
ROA-98.53%
ROE-154.28%
ROIC-404.93%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-40.50%
SMA50-58.27%
SMA200-85.99%
Trades-

Technical

Shs Outstand0.98M
Shs Float0.77M
Short Float4.62%
Short Ratio0.38
Short Interest0.04M
52W High19.50 -95.23%
52W Low0.97 -3.75%
Volatility10.90% 16.79%
ATR (14)0.26
RSI (14)26.91
Beta2.26
Rel Volume1.99
Avg Volume93.04K
Volume185,536

Performance

Perf Week-21.85%
Perf Month-62.80%
Perf Quarter-73.39%
Perf Half Y-89.01%
Perf YTD-89.42%
Perf Year-94.83%
Perf 3Y-99.42%
Perf 5Y-99.88%
Perf 10Y-99.92%
Recom2.00
Target Price450.00
Prev Close1.23
Price0.93
Change %-24.39%

Analyst ratings

latest 7 of 7
DateActionAnalystRating changeTargetImplied
May 11, 2021DowngradePPiper SandlerOverweight → Neutral
Aug 26, 2020ResumedPPiper SandlerOverweight
Jan 27, 2020InitiatedPPiper SandlerOverweight$3+222.6%
Jan 24, 2020InitiatedSSunTrustBuy
Jan 23, 2020InitiatedSSunTrustBuy
Jan 09, 2020InitiatedAAegis CapitalBuy$3.50+276.3%
Jun 26, 2019InitiatedHH.C. WainwrightBuy$4+330.1%

Peers

Mkt cap
TickerCompanyMkt cap
PLUGPlug Power Inc1.90B
BLDPBallard Power Systems Inc530.15M
FCELFuelcell Energy Inc875.50M
ORMPOramed Pharmaceuticals Inc171.80M
ENTXEntera Bio Ltd560.73M
BEBloom Energy Corp61.93B
CETYClean Energy Technologies Inc11.82M
VGASVerde Clean Fuels Inc44.33M
HYLNHyliion Holdings Corp496.50M
EOSEEos Energy Enterprises Inc729.06M

Held by

AUM
TickerCompanyAUM
VXFVanguard Extended Market Index ETFAUM: 30.47B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2024Q32024-11-06-12.750-15.825-12.7290.000.002
2024Q22024-08-14-15.000-18.750-17.2050.000.002
2024Q12024-05-09-22.500-22.500-20.0930.000.002
2023Q42024-03-27-15.000-22.500-18.3450.00-2
2023Q32023-11-08-22.500-21.825-20.903--2
2023Q22023-08-09-22.500-22.800-20.918-0.302
2023Q12023-05-10-22.500-22.500-19.0281.100.301
2022Q42023-03-15-15.000-18.975-12.5701.061.033
2022Q32022-11-02-22.500-22.275-18.8851.061.134
2022Q22022-08-11-22.500-25.200-20.4831.060.084
2022Q12022-05-12-22.500-20.025-20.6930.000.003
2021Q42022-03-08-22.500-25.350-23.2350.000.454
2021Q32021-11-08-22.500-14.550-23.8280.002.034
2021Q22021-08-10-15.000-22.500-18.1880.000.034
2021Q12021-05-10-22.500-19.725-19.0130.030.03-
2020Q42021-03-29-22.500-21.000-24.6750.061.025

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY-270-277.5-0.3600.15-
2018FY-112.5-108.75-114.590.120.16
2019FY-97.500-93.750-94.5150.090.12
2020FY-90.000-84.300-88.5230.161.12
2021FY-82.500-87.525-84.4950.030.35
2022FY-75.000--72.6303.19-
2023FY-82.500-82.500-82.5001.101.10
2024FY--60.900-74.759-0.00
2025FY--22.500-30.040-0.00
2026FY--75.000---
2027FY--37.500--45.20
2028FY-165--120.09

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2024Q4S2025-02-251000.000.000.00
2024Q4S2025-02-241000.000.000.00
2024Q4S2025-02-231000.000.000.00
2024Q4S2025-02-221000.000.000.00
2024Q4S2025-02-211000.000.000.00
2024Q4S2025-02-201000.000.000.00
2024Q4S2025-02-191000.000.000.00
2024Q4S2025-02-181000.000.000.00
2024Q4S2025-02-171000.000.000.00
2024Q4S2025-02-161000.000.000.00
2024Q4S2025-02-151000.000.000.00
2024Q4S2025-02-141000.000.000.00
2024Q4S2025-02-131000.000.000.00
2024Q4S2025-02-121000.000.000.00

Estimate history

EPS, annual-0.36-114.585-94.515-88.523-84.495-72.63-79.193-74.759-30.04-18.0126
Period201720182019202020212022202320242025TTM
EPS, quarterly-17.205-12.729-24.866-4.883-15.466-5.933-4.477-4.498-3.105
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual0.150.120.090.1580.0333.1881.096000
Period201720182019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual93.3710.1510.2180.2670.2880.290.290.3390.4270.427
Period201720182019202020212022202320242025MRQ
Shares, quarterly0.3340.3390.3390.3390.3390.3930.4270.4270.427
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue0.000.000.001.103.190.030.160.090.12
Cost of Goods Sold Incl. D&A0.290.460.970.940.900.78---
Gross Profit-0.29-0.46-0.970.152.29-0.75---
Selling, General and Administrative Excl. Other6.386.5019.1923.9226.8823.9923.5918.2314.55
Research and Development0.000.0911.4314.4916.6814.5814.3611.236.79
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-6.67-6.96-20.16-23.77-24.59-24.73-24.21-18.92-14.65
Unusual Expense-0.373.164.21-0.600.000.000.00--
Net Income Before Taxes-6.69-10.35-24.33-22.94-21.00-23.28-22.45-17.37-14.59
Income Taxes0.000.00-0.080.000.000.000.000.00-0.51
Consolidated Net Income-7.31-10.96-24.25-22.94-21.00-23.28-22.45-17.37-14.08
Net Income From Continuing Operations-7.31-10.96-24.25-22.94-21.00-23.28-22.45-17.37-14.08
Net Income-7.31-10.96-24.25-22.94-21.00-23.68-23.24-18.30-14.99
EPS (Recurring)-17.72-23.98-65.67-80.65-72.63-84.50-88.53-94.51-114.58
EPS (Basic, Before Extraordinaries)-18.01-30.04-74.76-79.19-72.63-84.50-88.52-94.52-114.58
EPS (Diluted)-18.01-30.04-74.76-79.19-72.63-84.50-88.52-94.52-114.58
EBITDA-6.38-6.50-19.19-22.82-23.69-23.95-23.43-18.14-14.43
Non-Operating Income (Expense)-0.39-0.220.040.223.591.451.761.550.06
Other After Tax Adjustments-0.62-0.620.000.000.000.000.000.000.00
Stock Option Compensation Expense0.691.022.524.955.234.294.562.993.03
Price To Sales Ratio---42.8634.006,368.471,691.223,669.81487.44
Gross Margin---14.1471.83-2,244.50---
Operating Margin----2,168.43-771.33-74,205.01-15,288.38-21,067.38-12,230.94
Net Margin----2,093.25-658.63-71,038.35-14,678.10-20,372.35-12,516.17
Shares Outstanding0.430.430.340.290.290.290.270.220.15
Market Capitalization1.201.202.5946.97108.43218.43272.15370.3767.41

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.000.070.100.110.120.130.250.24
Gross Profit-0.00-0.07-0.10-0.11-0.12-0.13-0.25-0.24
Selling, General and Administrative Excl. Other1.551.861.501.461.711.823.794.14
Research and Development0.000.000.000.000.000.092.382.24
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-1.55-1.94-1.60-1.58-1.84-1.95-4.04-4.38
Unusual Expense-0.370.000.000.003.46-0.294.43-0.05
Net Income Before Taxes-1.33-1.92-1.91-1.53-5.25-1.66-8.51-4.28
Income Taxes0.000.000.000.000.000.00-0.080.00
Consolidated Net Income-1.33-1.92-1.91-2.15-5.25-1.66-8.43-4.28
Net Income From Continuing Operations-1.33-1.92-1.91-2.15-5.25-1.66-8.43-4.28
Net Income-1.33-1.92-1.91-2.15-5.25-1.66-8.43-4.28
EPS (Recurring)-3.71-4.50-4.48-5.93-8.33-5.49-15.72-12.83
EPS (Basic, Before Extraordinaries)-3.10-4.50-4.48-5.93-15.47-4.88-24.87-12.73
EPS (Diluted)-3.10-4.50-4.48-5.93-15.47-4.88-24.87-12.73
EBITDA-1.55-1.86-1.50-1.46-1.71-1.82-3.79-4.14
Non-Operating Income (Expense)-0.140.01-0.310.040.05-0.00-0.040.06
Other After Tax Adjustments0.000.000.00-0.620.000.000.000.00
Stock Option Compensation Expense0.100.110.220.250.240.320.190.96
Shares Outstanding0.430.430.430.390.340.340.340.34
Market Capitalization1.203.203.7511.154.532.652.5918.01

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments4.057.3313.8128.8149.6758.8228.0312.557.46
Short Term Receivables0.000.000.000.000.000.000.000.000.00
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets0.030.691.745.721.322.741.900.540.50
Total Current Assets4.088.0315.5434.5350.9961.5529.9213.097.96
Net Property, Plant & Equipment0.672.165.015.735.784.865.632.041.57
Total Investments and Advances0.200.200.200.200.000.000.000.000.00
Intangible Assets2.262.264.354.354.354.354.354.354.35
Deferred Tax Assets--40.4734.05-----
Other Assets0.000.000.000.000.200.200.340.460.54
Total Assets7.2112.6465.5878.8761.3370.9740.2419.9414.42
Short Term Debt Incl. Current Port. of LT Debt0.700.770.660.570.560.420.480.280.20
Accounts Payable0.320.100.510.620.940.350.680.300.58
Other Current Liabilities0.451.801.453.102.852.801.942.261.44
Total Current Liabilities1.462.672.624.294.353.573.102.842.22
Long Term Debt0.662.132.903.564.143.333.750.110.07
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities0.260.2640.8134.390.340.340.340.340.85
Other Liabilities0.000.000.000.000.000.000.000.510.60
Total Liabilities2.385.0546.3342.238.837.247.193.803.74
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.003.803.999.785.72
Common Equity4.837.5919.2536.6452.4959.9329.076.364.97
Total Shareholders Equity4.837.5919.2536.6452.4963.7333.0516.1410.68
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity4.837.5919.2536.6452.4963.7333.0516.1410.68
Total Liabilities & Stockholders Equity7.2112.6465.5878.8761.3370.9740.2419.9414.42
Book Value Per Share11.3122.3866.44126.47182.04224.62133.6142.120.05
Tangible Book Value Per Share6.0215.7251.41111.44166.94208.30113.6013.290.01
Full-Time Employees4732343120211515
Price to Book Ratio0.290.342.032.814.164.5412.7410.6015.30
Return on Assets-110.46-62.01-31.77-29.95-35.20-40.37-57.73-81.96-265.91
Return on Equity-176.54-180.73-82.11-47.12-40.07-46.39-70.63-105.00-361.46
Return on Invested Capital-199.76-249.55-103.62-52.24-41.11-33.47-47.21-86.67-299.80
Quick Ratio2.793.015.938.0611.7317.259.664.613.58
Current Ratio2.793.015.938.0611.7317.259.664.613.58

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-6.69-10.35-24.25-22.94-21.00-23.28-22.45-17.37-14.08
Depreciation0.280.460.970.940.900.780.770.780.22
Other Funds (Non Cash)0.774.397.535.065.735.754.812.993.89
Funds from Operations-5.64-5.50-15.75-16.95-14.37-16.76-16.86-13.60-10.48
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-0.78-1.51-0.131.67-4.791.53-0.51-0.490.16
Cash from Operating Activities-6.42-7.01-15.88-15.28-19.16-15.22-17.37-14.09-10.32
Capital Expenditures0.000.000.00-0.22-0.89-0.26-0.01-0.41-0.54
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.340.340.000.000.000.000.000.00-
Purchase or Sale of Investments0.000.009.2113.465.7717.03-40.66-5.610.00
Purchase of Investments0.000.00-8.440.00-9.48-23.19-72.11-5.610.00
Sale Or Maturity of Investments0.000.0017.6413.4615.2540.2331.450.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities0.340.349.2113.244.8816.77-40.67-6.01-0.54
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock0.133.409.180.000.107.0048.1030.137.06
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock0.133.409.180.000.107.0048.1030.137.06
Proceedsfrom Stock Options0.003.279.180.000.005.5846.7030.107.06
Issuance or Reduction of Debt, Net-0.01-0.01-0.01-0.01-0.02-0.03-0.05-0.28-0.43
Change in Long Term Debt-0.01-0.01-0.01-0.01-0.02-0.03-0.05-0.08-0.06
Issuance of Long Term Debt0.000.000.000.000.000.000.000.00-
Reduction of Long Term Debt-0.01-0.01-0.01-0.01-0.02-0.03-0.05-0.08-0.06
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.009.24
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities0.123.399.17-0.010.086.9648.0529.8515.87
Net Change in Cash-5.96-3.292.50-2.04-14.208.51-9.999.755.01
Free Cash Flow---15.88-15.50-20.05-15.48-17.37-14.50-10.86
Preferred Dividends (Cash Flow)-0.000.000.000.00----
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00-0.51

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments0.812.454.055.496.586.97
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets0.330.370.030.170.690.57
Total Current Assets1.142.814.085.657.277.55
Net Property, Plant & Equipment0.010.600.671.511.632.03
Total Investments and Advances0.000.200.200.200.200.20
Intangible Assets2.262.262.262.262.262.26
Other Assets0.000.000.000.070.070.00
Total Assets3.415.877.219.7011.4212.04
Short Term Debt Incl. Current Port. of LT Debt0.000.720.700.850.820.79
Accounts Payable0.840.710.320.080.170.28
Other Current Liabilities0.500.690.450.560.801.18
Total Current Liabilities1.352.131.461.501.782.25
Long Term Debt0.010.470.661.481.711.92
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities0.260.260.260.260.260.26
Other Liabilities0.000.000.000.000.001.33
Total Liabilities1.612.852.383.233.755.76
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity1.803.024.836.467.676.27
Total Shareholders Equity1.803.024.836.467.676.27
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity1.803.024.836.467.676.27
Total Liabilities & Stockholders Equity3.415.877.219.7011.4212.04
Book Value Per Share4.217.0811.3116.4222.6318.49
Tangible Book Value Per Share-1.081.786.0210.6815.9711.82
Full-Time Employees--4---
Price to Book Ratio0.291.060.781.730.590.42
Return on Assets-98.53-125.39-110.46-115.51-109.58-126.93
Return on Equity-154.28-241.67-176.54-157.24-146.46-192.85
Return on Invested Capital-73.46-55.03-34.84-27.07-55.90-20.22
Quick Ratio0.851.322.793.784.073.35
Current Ratio0.851.322.793.784.073.35

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-1.33-1.92-1.91-1.53-5.25-1.66
Depreciation0.000.070.100.110.120.13
Other Funds (Non Cash)-0.130.110.530.253.580.02
Funds from Operations-1.45-1.73-1.29-1.17-1.54-1.51
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.390.13-0.22-0.31-0.48-0.50
Cash from Operating Activities-1.84-1.60-1.51-1.47-2.02-2.01
Capital Expenditures0.000.000.000.000.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.010.320.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities0.000.000.010.320.000.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.000.070.061.621.65
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.070.061.621.65
Proceedsfrom Stock Options0.000.000.000.001.621.65
Issuance or Reduction of Debt, Net-0.000.00-0.010.00-0.00-0.00
Change in Long Term Debt-0.000.00-0.010.00-0.00-0.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.000.00-0.010.00-0.00-0.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.000.000.060.061.621.65
Net Change in Cash-1.84-1.60-1.44-1.09-0.40-0.36
Free Cash Flow-1.84-1.60---2.02-2.01

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.62%0.0M0.8M92.60K
2026-10-156.42%0.0M0.8M383.56K
2026-09-307.29%0.1M0.8M388.94K
2026-09-153.80%0.0M0.8M375.01K
2026-08-312.79%0.0M0.7M359.62K
2026-08-142.00%0.0M0.7M352.66K
2026-07-317.35%0.1M0.8M343.41K
2026-07-155.34%0.0M0.6M32.29K
2026-06-300.12%0.0M0.3M10.14K
2026-06-150.39%0.0M0.3M9.59K
2026-05-291.32%0.0M0.3M9.00K
2026-05-150.01%0.0M0.3M1.77K
2026-04-300.09%0.0M0.3M1.81K
2026-04-150.07%0.0M0.3M1.94K
2026-03-310.17%0.0M0.3M1.92K
2026-03-130.14%0.0M0.3M2.08K
2026-02-270.09%0.0M0.3M2.28K
2026-02-130.11%0.0M0.3M2.40K
2026-01-300.01%0.0M0.3M2.20K
2026-01-150.01%0.0M0.3M1.97K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-094/A2026-11-06SEC
2026-11-094/A2026-11-06SEC
2026-11-094/A2026-11-06SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-09-288-KCurrent report2026-09-25SEC
2026-09-168-KCurrent report2026-09-16SEC
2026-09-048-KCurrent report2026-08-31SEC
2026-08-25425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-08-1310-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-13SCHEDULE 13D/ASEC
2026-08-134Statement of changes in beneficial ownership of securities2025-10-16SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-08-04425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-07-30425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-07-29425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-07-248-KCurrent report2026-07-23SEC
2026-07-21425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-07-16425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-07-14SCHEDULE 13GSEC
2026-07-13425Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions.SEC
2026-07-138-KCurrent report2026-07-10SEC
2026-06-268-KCurrent report2026-06-24SEC
2026-06-22424B7SEC
2026-06-16S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-05-0810-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-038-KCurrent report2026-04-02SEC
2026-03-3110-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
RENAISSANCE TECHNOLOGIES LLC1.11%
BlackRock, Inc.0.78%
GEODE CAPITAL MANAGEMENT, LLC0.77%
VANGUARD CAPITAL MANAGEMENT LLC0.63%
VANGUARD FIDUCIARY TRUST CO0.27%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.25%
CITADEL ADVISORS LLC0.24%
STATE STREET CORP0.24%
Holos Integrated Wealth LLC0.22%
Sargent Investment Group, LLC0.20%

Funds

Fund% owned
VANGUARD EXTENDED MARKET INDEX FUND0.63%
Fidelity Extended Market Index Fund0.22%
Fidelity Total Market Index Fund0.05%
Fidelity Series Total Market Index Fund0.04%

OakChart. MTNB. Cached 15 minutes.

Some panels did not load: insider.